Rocket Pharmaceuticals (RCKT)
Rocket Pharmaceuticals on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as pharmaceutical preparations.
16.3M
Short interest
settlement 2026-10-15
6.7
Days to cover
-0.3 days vs prior
51.6%
Short share of volume
2026-11-03
60
Fails to deliver
settlement 2026-10-14
Thu 5 Nov
Next earnings
estimated date
-$432K
Insider flow, 90 days
0 buys, 7 sells
As of 2026-11-03.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in RCKT is 16,281,767 shares, up 1,434,289 shares over the last month. Over the last 48 readings it ranged from 10,386,199 shares (29 November 2024) to 22,449,450 shares (29 May 2026). At the reported average volume of 2.4M shares a day that is 6.7 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/rckt" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 16,281,767 | +8.2% | 2,436,032 | 6.68 |
| 2026-09-30 | 15,049,780 | +1.4% | 2,169,320 | 6.94 |
| 2026-09-15 | 14,847,478 | +0.9% | 1,337,248 | 11.10 |
| 2026-08-31 | 14,711,952 | +2.2% | 1,503,342 | 9.79 |
| 2026-08-14 | 14,391,319 | -7.1% | 1,682,140 | 8.56 |
| 2026-07-31 | 15,495,507 | -6.5% | 1,301,655 | 11.90 |
| 2026-07-15 | 16,571,867 | -8.7% | 2,436,638 | 6.80 |
| 2026-06-30 | 18,159,054 | -17.1% | 3,646,821 | 4.98 |
| 2026-06-15 | 21,899,491 | -2.5% | 2,622,663 | 8.35 |
| 2026-05-29 | 22,449,450 | +7.2% | 2,357,401 | 9.52 |
| 2026-05-15 | 20,949,087 | -2.8% | 2,075,966 | 10.09 |
| 2026-04-30 | 21,549,583 | +13.0% | 2,015,613 | 10.69 |
| 2026-04-15 | 19,076,324 | +2.7% | 2,607,007 | 7.32 |
| 2026-03-31 | 18,580,923 | +26.5% | 6,423,862 | 2.89 |
| 2026-03-13 | 14,693,507 | +5.1% | 3,407,537 | 4.31 |
| 2026-02-27 | 13,986,075 | -3.3% | 2,802,884 | 4.99 |
| 2026-02-13 | 14,457,332 | +3.9% | 1,823,895 | 7.93 |
| 2026-01-30 | 13,914,138 | +3.9% | 2,245,466 | 6.20 |
| 2026-01-15 | 13,387,606 | +5.0% | 2,247,839 | 5.96 |
| 2025-12-31 | 12,743,607 | +7.0% | 1,653,477 | 7.71 |
| 2025-12-15 | 11,908,746 | +8.0% | 2,229,341 | 5.34 |
| 2025-11-28 | 11,029,132 | -4.5% | 2,126,961 | 5.19 |
| 2025-11-14 | 11,555,436 | +4.7% | 2,049,049 | 5.64 |
| 2025-10-31 | 11,034,830 | -11.0% | 1,869,231 | 5.90 |
| 2025-10-15 | 12,397,844 | -9.5% | 3,958,365 | 3.13 |
| 2025-09-30 | 13,700,652 | -8.0% | 2,389,817 | 5.73 |
| 2025-09-15 | 14,892,250 | -3.9% | 1,699,209 | 8.76 |
| 2025-08-29 | 15,488,041 | +32.1% | 9,692,104 | 1.60 |
| 2025-08-15 | 11,725,943 | +4.4% | 2,200,776 | 5.33 |
| 2025-07-31 | 11,233,730 | -12.9% | 3,715,417 | 3.02 |
| 2025-07-15 | 12,898,169 | -5.0% | 2,819,104 | 4.58 |
| 2025-06-30 | 13,582,989 | -3.3% | 4,447,629 | 3.05 |
| 2025-06-13 | 14,041,698 | +11.0% | 5,087,275 | 2.76 |
| 2025-05-30 | 12,645,316 | -9.3% | 10,589,568 | 1.19 |
| 2025-05-15 | 13,943,338 | +13.8% | 3,505,058 | 3.98 |
| 2025-04-30 | 12,256,529 | -7.8% | 2,658,596 | 4.61 |
| 2025-04-15 | 13,298,511 | +6.9% | 4,930,226 | 2.70 |
| 2025-03-31 | 12,437,730 | +12.6% | 2,041,869 | 6.09 |
| 2025-03-14 | 11,045,587 | +0.1% | 1,512,235 | 7.30 |
| 2025-02-28 | 11,035,189 | -1.8% | 1,228,659 | 8.98 |
| 2025-02-14 | 11,238,937 | +6.8% | 1,226,041 | 9.17 |
| 2025-01-31 | 10,521,361 | -10.1% | 1,571,696 | 6.69 |
| 2025-01-15 | 11,701,825 | -9.5% | 1,669,089 | 7.01 |
| 2024-12-31 | 12,927,098 | +15.7% | 1,733,193 | 7.46 |
| 2024-12-13 | 11,175,314 | +7.6% | 1,404,837 | 7.95 |
| 2024-11-29 | 10,386,199 | -6.4% | 1,147,683 | 9.05 |
| 2024-11-15 | 11,092,305 | -6.8% | 859,992 | 12.90 |
| 2024-10-31 | 11,897,507 | +3.3% | 621,729 | 19.14 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 3 November 2026, the short share of RCKT volume is 51.6%, up 0.7 points over the last five sessions. Over the last 30 readings it ranged from 42.4% (29 October 2026) to 64.8% (6 October 2026). The latest reading is 2.3 points below the 30-session average of 53.8%, on 573K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-03 | 296K | 573K | 51.6% | 0 |
| 2026-11-02 | 440K | 794K | 55.4% | 0 |
| 2026-10-30 | 387K | 809K | 47.8% | 1,111 |
| 2026-10-29 | 374K | 882K | 42.4% | 445 |
| 2026-10-28 | 303K | 592K | 51.1% | 7,313 |
| 2026-10-27 | 484K | 950K | 50.9% | 0 |
| 2026-10-26 | 433K | 707K | 61.3% | 1,000 |
| 2026-10-23 | 305K | 594K | 51.3% | 0 |
| 2026-10-22 | 371K | 847K | 43.9% | 16,041 |
| 2026-10-21 | 534K | 1.0M | 53.3% | 1,268 |
| 2026-10-20 | 412K | 782K | 52.6% | 571 |
| 2026-10-19 | 409K | 805K | 50.8% | 430 |
| 2026-10-16 | 629K | 1.1M | 58.0% | 9,802 |
| 2026-10-15 | 484K | 881K | 54.9% | 116 |
| 2026-10-14 | 480K | 952K | 50.4% | 1,370 |
| 2026-10-13 | 973K | 1.7M | 57.2% | 3,036 |
| 2026-10-12 | 557K | 1.1M | 50.1% | 4,068 |
| 2026-10-09 | 682K | 1.5M | 46.9% | 2,941 |
| 2026-10-08 | 839K | 1.4M | 59.1% | 2,149 |
| 2026-10-07 | 807K | 1.3M | 60.5% | 1,233 |
| 2026-10-06 | 590K | 910K | 64.8% | 2,549 |
| 2026-10-05 | 437K | 875K | 49.9% | 290 |
| 2026-10-02 | 545K | 1.0M | 54.0% | 1,770 |
| 2026-10-01 | 483K | 1.0M | 48.2% | 18,641 |
| 2026-09-30 | 649K | 1.2M | 55.6% | 498 |
| 2026-09-29 | 342K | 602K | 56.7% | 0 |
| 2026-09-28 | 574K | 972K | 59.1% | 135 |
| 2026-09-25 | 705K | 1.2M | 56.7% | 95,169 |
| 2026-09-24 | 1.5M | 2.6M | 57.6% | 261,660 |
| 2026-09-23 | 989K | 1.6M | 62.9% | 46,054 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 14 October 2026, the fails-to-deliver balance in RCKT is 60 shares, down 325 shares over the last settlement date. Over the last 30 readings it ranged from 2 shares (11 May 2026) to 61,710 shares (15 May 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-14 | 60 | $2.30 | $138 |
| 2026-10-13 | 385 | $2.48 | $955 |
| 2026-09-11 | 7 | $3.48 | $24 |
| 2026-09-09 | 13,803 | $3.71 | $51K |
| 2026-09-04 | 141 | $3.79 | $534 |
| 2026-09-01 | 694 | $3.72 | $3K |
| 2026-08-31 | 28,613 | $3.86 | $110K |
| 2026-08-21 | 1,165 | $3.48 | $4K |
| 2026-08-04 | 322 | $3.41 | $1K |
| 2026-07-30 | 1,333 | $3.14 | $4K |
| 2026-07-17 | 29 | $3.41 | $99 |
| 2026-07-10 | 4,000 | $4.19 | $17K |
| 2026-07-01 | 12 | $3.42 | $41 |
| 2026-06-24 | 100 | $3.47 | $347 |
| 2026-06-23 | 2,535 | $3.46 | $9K |
| 2026-06-18 | 140 | $3.16 | $442 |
| 2026-06-17 | 6,356 | $2.80 | $18K |
| 2026-06-12 | 50 | $2.66 | $133 |
| 2026-06-11 | 16,653 | $2.60 | $43K |
| 2026-05-29 | 80 | $3.02 | $242 |
| 2026-05-18 | 623 | $3.25 | $2K |
| 2026-05-15 | 61,710 | $3.40 | $210K |
| 2026-05-11 | 2 | $3.63 | $7 |
| 2026-05-08 | 7,695 | $3.67 | $28K |
| 2026-05-05 | 59 | $3.61 | $213 |
| 2026-05-01 | 233 | $3.48 | $811 |
| 2026-04-28 | 9,196 | $3.49 | $32K |
| 2026-04-27 | 159 | $3.52 | $560 |
| 2026-04-23 | 2,212 | $3.80 | $8K |
| 2026-04-22 | 3,335 | $3.66 | $12K |
Insider trades
SEC Form 4, newest first. JSONInsiders at RCKT reported 7 open-market sells worth $432K in the last 90 days and no open-market buys. Latest filing: Wilson Martin (General Counsel) on 2026-09-11.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-09-11 | Wilson Martin | General Counsel | Sell | 75K | $3.40 | $256K | 598K |
| 2026-08-18 | Wilson Martin | General Counsel | Sell | 631 | $3.38 | $2K | 674K |
| 2026-08-18 | Shah Gaurav | CEO | Sell | 2K | $3.38 | $8K | 1.1M |
| 2026-08-13 | Shah Gaurav | CEO | Sell | 3K | $3.38 | $10K | 1.1M |
| 2026-08-13 | Wilson Martin | General Counsel | Sell | 3K | $3.38 | $12K | 674K |
| 2026-08-11 | Stevens Christopher James | Chief Operating Officer | Sell | 37K | $3.50 | $128K | 506K |
| 2026-08-11 | Chaudhuri Sarbani | See Remarks | Sell | 5K | $3.50 | $16K | 263K |
| 2026-08-03 | Stevens Christopher James | Chief Operating Officer | Grant | 73K | $0.00 | $0 | 542K |
| 2026-08-03 | SOUTHWELL DAVID P | Director | Other transaction | 150K | $0.00 | $0 | 205K |
| 2026-06-18 | WONG RODERICK | Director, 10% owner | Grant | 28K | $0.00 | $0 | 75K |
| 2026-06-18 | SOUTHWELL DAVID P | Director | Grant | 23K | $0.00 | $0 | 55K |
| 2026-06-18 | Malik Fady Ibraham | Director | Grant | 23K | $0.00 | $0 | 53K |
| 2026-06-18 | Fong Peter | Director | Grant | 23K | $0.00 | $0 | 76K |
| 2026-06-18 | Dolsten Mikael | Director | Grant | 23K | $0.00 | $0 | 67K |
| 2026-06-18 | BOESS CARSTEN | Director | Grant | 23K | $0.00 | $0 | 53K |
| 2026-05-21 | Shah Gaurav | CEO | Sell | 56K | $3.09 | $172K | 1.1M |
| 2026-05-21 | Shah Gaurav | CEO | Exercise or conversion | 76K | $1.69 | $129K | 1.1M |
| 2026-05-19 | Shah Gaurav | CEO | Sell | 2K | $3.01 | $7K | 1.0M |
| 2026-05-19 | Wilson Martin | General Counsel | Sell | 662 | $3.01 | $2K | 678K |
| 2026-05-19 | Militello John | See Remarks | Sell | 384 | $3.01 | $1K | 90K |
| 2026-05-13 | Wilson Martin | General Counsel | Sell | 3K | $3.61 | $12K | 679K |
| 2026-05-13 | Shah Gaurav | CEO | Sell | 3K | $3.61 | $10K | 1.0M |
| 2026-05-13 | Militello John | See Remarks | Sell | 855 | $3.61 | $3K | 90K |
| 2026-05-07 | Chaudhuri Sarbani | See Remarks | Sell | 18K | $3.84 | $68K | 268K |
| 2026-02-18 | Shah Gaurav | CEO | Sell | 6K | $3.34 | $20K | 1.0M |
| 2026-02-18 | Wilson Martin | General Counsel | Sell | 1K | $3.34 | $5K | 682K |
| 2026-02-18 | Militello John | See Remarks | Sell | 1K | $3.34 | $4K | 91K |
| 2026-02-13 | Wilson Martin | General Counsel | Sell | 12K | $3.31 | $41K | 683K |
| 2026-02-13 | Shah Gaurav | CEO | Sell | 12K | $3.31 | $41K | 1.1M |
| 2026-02-13 | Militello John | See Remarks | Sell | 4K | $3.31 | $12K | 92K |
| 2026-02-11 | Shah Gaurav | CEO | Grant | 286K | $0.00 | $0 | 1.1M |
| 2026-02-11 | Wilson Martin | General Counsel | Grant | 312K | $0.00 | $0 | 696K |
| 2026-02-11 | Rizvi Syed Ali-aamir | Chief Medical Officer | Grant | 62K | $0.00 | $0 | 408K |
| 2026-02-11 | Stevens Christopher James | Chief Operating Officer | Grant | 62K | $0.00 | $0 | 469K |
| 2026-02-11 | Militello John | See Remarks | Grant | 30K | $0.00 | $0 | 96K |
| 2026-02-11 | Chaudhuri Sarbani | See Remarks | Grant | 126K | $0.00 | $0 | 285K |
| 2026-01-02 | Bjork Elisabeth | Director | Buy | 10K | $3.44 | $34K | 50K |
| 2025-11-18 | Schwartz Jonathan David | See Remarks | Sell | 3K | $2.98 | $8K | 299K |
| 2025-11-18 | Shah Gaurav | CEO | Sell | 6K | $2.98 | $19K | 778K |
| 2025-11-18 | Wilson Martin | General Counsel | Sell | 2K | $2.98 | $5K | 384K |
| 2025-11-18 | Militello John | See Remarks | Sell | 1K | $2.98 | $3K | 66K |
| 2025-11-03 | Wilson Martin | General Counsel | Grant | 100K | $0.00 | $0 | 385K |
| 2025-10-14 | Militello John | See Remarks | Sell | 558 | $3.98 | $2K | 67K |
| 2025-10-14 | Militello John | See Remarks | Sell | 3K | $3.97 | $12K | 68K |
| 2025-10-14 | Militello John | See Remarks | Sell | 6K | $3.96 | $22K | 71K |
| 2025-10-14 | Militello John | See Remarks | Sell | 20K | $3.96 | $79K | 76K |
| 2025-10-06 | Rizvi Syed Ali-aamir | Chief Medical Officer | Grant | 63K | $0.00 | $0 | 346K |
| 2025-10-06 | Rizvi Syed Ali-aamir | Chief Medical Officer | Grant | 283K | $0.00 | $0 | 283K |
| 2025-09-24 | Fong Peter | Director | Grant | 30K | $0.00 | $0 | 53K |
| 2025-09-24 | Fong Peter | Director | Grant | 23K | $0.00 | $0 | 23K |
| 2025-09-19 | RTW INVESTMENTS, LP | Director, 10% owner, See remarks | Other transaction | 59K | $3.10 | $183K | 18.2M |
| 2025-09-19 | RTW INVESTMENTS, LP | Director, 10% owner, See remarks | Exercise (in or at the money) | 59K | $17.81 | $1.1M | 18.2M |
| 2025-09-19 | RTW INVESTMENTS, LP | Director, 10% owner, See remarks | Other transaction | 41K | $3.10 | $127K | 18.2M |
| 2025-09-19 | RTW INVESTMENTS, LP | Director, 10% owner, See remarks | Exercise (in or at the money) | 41K | $19.09 | $783K | 18.2M |
| 2025-09-19 | RTW INVESTMENTS, LP | Director, 10% owner, See remarks | Other transaction | 1.0M | $3.10 | $3.1M | 18.2M |
| 2025-09-19 | RTW INVESTMENTS, LP | Director, 10% owner, See remarks | Exercise (in or at the money) | 1.0M | $40.03 | $40.0M | 19.2M |
| 2025-09-08 | Wilson Martin | General Counsel | Grant | 150K | $0.00 | $0 | 285K |
| 2025-09-08 | Schwartz Jonathan David | See Remarks | Grant | 80K | $0.00 | $0 | 302K |
| 2025-09-08 | Militello John | See Remarks | Grant | 40K | $0.00 | $0 | 96K |
| 2025-08-27 | Bjork Elisabeth | Director | Buy | 10K | $3.41 | $34K | 40K |
| 2025-08-19 | Schwartz Jonathan David | See Remarks | Sell | 805 | $3.00 | $2K | 222K |
| 2025-08-19 | Wilson Martin | General Counsel | Sell | 588 | $3.00 | $2K | 135K |
| 2025-08-19 | Militello John | See Remarks | Sell | 361 | $3.00 | $1K | 56K |
| 2025-08-18 | Schwartz Jonathan David | See Remarks | Sell | 2K | $3.06 | $5K | 222K |
| 2025-08-18 | Wilson Martin | General Counsel | Sell | 1K | $3.06 | $3K | 136K |
| 2025-08-18 | Shah Gaurav | CEO | Tax withholding | 2K | $3.05 | $7K | 785K |
| 2025-08-18 | Militello John | See Remarks | Sell | 699 | $3.06 | $2K | 56K |
| 2025-08-14 | Schwartz Jonathan David | See Remarks | Sell | 11K | $3.02 | $34K | 224K |
| 2025-08-14 | Wilson Martin | General Counsel | Sell | 12K | $3.02 | $37K | 137K |
| 2025-08-14 | Militello John | See Remarks | Sell | 7K | $3.02 | $21K | 57K |
| 2025-08-04 | Stevens Christopher James | Chief Operating Officer | Grant | 407K | $0.00 | $0 | 407K |
| 2025-07-03 | Ondrey Aaron | Chief Financial Officer | Sell | 1K | $2.88 | $4K | 128K |
| 2025-06-18 | WONG RODERICK | Director, 10% owner | Grant | 18K | $0.00 | $0 | 48K |
| 2025-06-18 | WONG RODERICK | Director, 10% owner | Grant | 30K | $0.00 | $0 | 30K |
| 2025-06-18 | SOUTHWELL DAVID P | Director | Grant | 30K | $0.00 | $0 | 32K |
| 2025-06-18 | Pratumsuwan Piratip | Director | Grant | 30K | $0.00 | $0 | 30K |
| 2025-06-18 | Malik Fady Ibraham | Director | Grant | 30K | $0.00 | $0 | 30K |
| 2025-06-18 | Makker Gotham | Director | Grant | 19K | $0.00 | $0 | 415K |
| 2025-06-18 | Makker Gotham | Director | Grant | 30K | $0.00 | $0 | 396K |
| 2025-06-18 | GRANADILLO PEDRO P | Director | Grant | 25K | $0.00 | $0 | 55K |
| 2025-06-18 | GRANADILLO PEDRO P | Director | Grant | 30K | $0.00 | $0 | 30K |
| 2025-06-18 | Dolsten Mikael | Director | Grant | 30K | $0.00 | $0 | 44K |
| 2025-06-18 | Bjork Elisabeth | Director | Grant | 30K | $0.00 | $0 | 30K |
| 2025-06-18 | BOESS CARSTEN | Director | Grant | 30K | $0.00 | $0 | 30K |
| 2025-05-20 | Wilson Martin | General Counsel | Sell | 587 | $6.45 | $4K | 149K |
| 2025-05-20 | Shah Gaurav | CEO | Sell | 2K | $6.45 | $15K | 787K |
| 2025-05-20 | Patel Kinnari | See Remarks | Sell | 767 | $6.45 | $5K | 442K |
| 2025-05-20 | Schwartz Jonathan David | See Remarks | Sell | 801 | $6.45 | $5K | 235K |
| 2025-05-20 | Militello John | See Remarks | Sell | 357 | $6.45 | $2K | 64K |
| 2025-05-16 | Wilson Martin | General Counsel | Sell | 946 | $6.53 | $6K | 150K |
| 2025-05-16 | Shah Gaurav | CEO | Sell | 4K | $6.53 | $24K | 789K |
| 2025-05-16 | Schwartz Jonathan David | See Remarks | Sell | 2K | $6.53 | $10K | 236K |
| 2025-05-16 | Patel Kinnari | See Remarks | Sell | 1K | $6.53 | $9K | 443K |
| 2025-05-16 | Militello John | See Remarks | Sell | 655 | $6.53 | $4K | 64K |
| 2025-04-22 | Militello John | See Remarks | Sell | 718 | $7.16 | $5K | 65K |
| 2025-04-10 | Shah Gaurav | CEO | Buy | 20K | $5.08 | $102K | 793K |
| 2025-04-09 | Patel Kinnari | See Remarks | Buy | 21K | $4.70 | $99K | 27K |
| 2025-04-04 | Ondrey Aaron | Chief Financial Officer | Sell | 7K | $5.29 | $40K | 130K |
| 2025-03-05 | Dolsten Mikael | Director | Other transaction | 14K | $0.00 | $0 | 14K |
| 2025-02-25 | Schwartz Jonathan David | See Remarks | Sell | 7K | $10.58 | $69K | 238K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON32 Form 144 notices on file for RCKT worth $1.1M at the prices reported; 11 in the last 90 days worth $513K. Latest: Militello John filed on 2026-09-15 to sell 6,897 shares ($23K) from 2026-09-15.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-09-15 | Militello JohnFormer Officer | 7K | $23K | 0.006% | 2026-09-15 | Fidelity Brokerage Services LLC |
| 2026-09-14 | Militello JohnFormer Officer | 7K | $23K | 0.006% | 2026-09-14 | Fidelity Brokerage Services LLC |
| 2026-09-11 | Wilson MartinOfficer | 75K | $256K | 0.069% | 2026-09-11 | Fidelity Brokerage Services LLC |
| 2026-09-11 | Militello JohnFormer Officer | 9K | $30K | 0.008% | 2026-09-11 | Fidelity Brokerage Services LLC |
| 2026-08-18 | Shah GauravOfficer, Director | 2K | $8K | 0.002% | 2026-08-18 | Fidelity Brokerage Services LLC |
| 2026-08-18 | Wilson MartinOfficer | 631 | $2K | 0.001% | 2026-08-18 | Fidelity Brokerage Services LLC |
| 2026-08-18 | Militello JohnFormer Officer | 1K | $4K | 0.001% | 2026-08-18 | Fidelity Brokerage Services LLC |
| 2026-08-13 | Wilson MartinOfficer | 3K | $12K | 0.003% | 2026-08-13 | Fidelity Brokerage Services LLC |
| 2026-08-13 | Shah GauravOfficer, Director | 3K | $10K | 0.003% | 2026-08-13 | Fidelity Brokerage Services LLC |
| 2026-08-11 | Stevens Christopher JamesOfficer | 37K | $128K | 0.033% | 2026-08-11 | Fidelity Brokerage Services LLC |
| 2026-08-11 | Chaudhuri SarbaniOfficer | 5K | $16K | 0.004% | 2026-08-11 | Fidelity Brokerage Services LLC |
| 2026-07-07 | Malik Fady IbrahamDirector | 11K | $41K | 0.010% | 2026-07-07 | Fidelity Brokerage Services LLC |
| 2026-05-21 | Shah GauravOfficer, Director | 56K | $172K | 0.051% | 2026-05-21 | Fidelity Brokerage Services LLC |
| 2026-05-19 | Shah GauravOfficer, Director | 2K | $7K | 0.002% | 2026-05-19 | Fidelity Brokerage Services LLC |
| 2026-05-19 | Wilson MartinOfficer | 662 | $2K | 0.001% | 2026-05-19 | Fidelity Brokerage Services LLC |
| 2026-05-19 | Militello JohnOfficer | 384 | $1K | 0.000% | 2026-05-19 | Fidelity Brokerage Services LLC |
| 2026-05-13 | Wilson MartinOfficer | 3K | $12K | 0.003% | 2026-05-13 | Fidelity Brokerage Services LLC |
| 2026-05-13 | Shah GauravOfficer, Director | 3K | $10K | 0.002% | 2026-05-13 | Fidelity Brokerage Services LLC |
| 2026-05-13 | Militello JohnOfficer | 855 | $3K | 0.001% | 2026-05-13 | Fidelity Brokerage Services LLC |
| 2026-05-07 | Chaudhuri SarbaniOfficer | 18K | $68K | 0.016% | 2026-05-07 | Fidelity Brokerage Services LLC |
| 2026-02-18 | Wilson MartinOfficer | 1K | $5K | 0.001% | 2026-02-18 | Fidelity Brokerage Services LLC |
| 2026-02-18 | Shah GauravOfficer, Director | 6K | $20K | 0.006% | 2026-02-18 | Fidelity Brokerage Services LLC |
| 2026-02-18 | Militello JohnOfficer | 1K | $4K | 0.001% | 2026-02-18 | Fidelity Brokerage Services LLC |
| 2026-02-13 | Wilson MartinOfficer | 12K | $41K | 0.011% | 2026-02-13 | Fidelity Brokerage Services LLC |
| 2026-02-13 | Shah GauravOfficer, Director | 12K | $41K | 0.011% | 2026-02-13 | Fidelity Brokerage Services LLC |
| 2026-02-13 | Schwartz Jonathan DavidOfficer | 15K | $48K | 0.013% | 2026-02-13 | Fidelity Brokerage Services LLC |
| 2026-02-13 | Militello JohnOfficer | 4K | $12K | 0.003% | 2026-02-13 | Fidelity Brokerage Services LLC |
| 2025-11-18 | Schwartz Jonathan DavidOfficer | 3K | $8K | 0.002% | 2025-11-18 | Fidelity Brokerage Services LLC |
| 2025-11-18 | Shah GauravOfficer, Director | 6K | $19K | 0.006% | 2025-11-18 | Fidelity Brokerage Services LLC |
| 2025-11-18 | Wilson MartinOfficer | 2K | $5K | 0.002% | 2025-11-18 | Fidelity Brokerage Services LLC |
| 2025-11-18 | Militello JohnOfficer | 1K | $3K | 0.001% | 2025-11-18 | Fidelity Brokerage Services LLC |
| 2025-10-14 | Militello JohnOfficer | 29K | $115K | 0.027% | 2025-10-14 | Fidelity Brokerage Services LLC |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSONNo holder on file reports 5% or more of RCKT in its latest filing.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-10-30 | 13G/Ano. 1 | Vanguard Portfolio Managementinvestment adviser | 1.5M | 1.3% | 2026-09-30 |
| 2026-03-27 | 13G/Ano. 4 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
| 2026-02-13 | 13G/Ano. 2 | Maverick Capital, Ltd.investment adviser | 2.5M | 2.3% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 2 | Maverick Capital Management, LLCparent holding company | 2.5M | 2.3% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 2 | Lee S. Ainslie IIIindividual | 2.5M | 2.3% | 2025-12-31 |
13F holders
Tracked managers holding RCKT at their latest 13F. JSON7 of the 30 tracked managers held RCKT at their latest 13F, $34.8M in total at quarter-end prices. Millennium Management is the largest at $13.7M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 4 added shares and 3 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Millennium Management | 2026-06-30 | 4.0M | $13.7M | 0.01% | +882K |
| AQR Capital Management | 2026-06-30 | 3.4M | $11.6M | 0.00% | +316K |
| D. E. Shaw & Co. | 2026-06-30 | 951K | $3.3M | 0.00% | -1.2M |
| Renaissance Technologies | 2026-06-30 | 793K | $2.7M | 0.00% | +156K |
| Point72 Asset Management | 2026-06-30 | 671K | $2.3M | 0.00% | -342K |
| Two Sigma Investments | 2026-06-30 | 316K | $1.1M | 0.00% | -782K |
| Citadel Advisors | 2026-06-30 | 71K | $243K | 0.00% | new |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 FY 2026 (quarter ended 2026-06-30) Rocket Pharmaceuticals reported revenue of $0, and net income of $123.2M (1.08 diluted EPS). In FY 2025 it generated -$190.0M of operating cash flow.
- Cash
- $224.5M
- Equity
- $368.8M
- Total assets
- $423.1M
- Shares outstanding
- 109,774,597
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 FY 2026 | 2026-06-30 | $0 | $123.2M | n/a | 1.08 |
| Q1 FY 2026 | 2026-03-31 | $0 | -$47.6M | n/a | -0.42 |
| Q4 FY 2025derived | 2025-12-31 | $0 | n/a | n/a | n/a |
| Q3 FY 2025 | 2025-09-30 | $0 | -$50.3M | n/a | -0.45 |
| Q2 FY 2025 | 2025-06-30 | $0 | -$68.9M | n/a | -0.62 |
| Q1 FY 2025 | 2025-03-31 | $0 | -$61.3M | n/a | -0.56 |
| Q4 FY 2024derived | 2024-12-31 | $0 | n/a | n/a | n/a |
| Q3 FY 2024 | 2024-09-30 | $0 | -$66.7M | n/a | -0.71 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $0 | -$223.1M | -$190.0M | $440K | n/a | n/a |
| FY 2024 | 2024-12-31 | $0 | -$258.7M | -$209.7M | $5.9M | n/a | n/a |
| FY 2023 | 2023-12-31 | $0 | -$245.6M | -$194.9M | $16.4M | n/a | n/a |
| FY 2022 | 2022-12-31 | $0 | -$221.9M | -$178.1M | $8.4M | n/a | n/a |
| FY 2021 | 2021-12-31 | $0 | -$169.1M | -$121.2M | $7.6M | $0 | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-31 from the cover page.
What this page is
Rocket Pharmaceuticals in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Rocket Pharmaceuticals (RCKT), SEC CIK 1281895, listed on Nasdaq, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-03.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-14.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-09-15.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-10-30.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-10.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-09-11.JSON and CSV
- Company record
- EDGAR filing index for CIK 1281895Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as pharmaceutical preparations
Other company pages
Datasets
Frequently Asked Questions
How much of RCKT is sold short?
16,281,767 shares were held short at the 2026-10-15 settlement, 6.7 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is RCKT's daily short volume?
On 2026-11-03, 295,759 of the 573,403 RCKT shares reported to FINRA were sold short, 51.6% of the day's reported volume. Short volume is a flow for one day, not a position.
Does RCKT have fails to deliver?
The SEC's latest file shows 60 RCKT shares failed to deliver at settlement 2026-10-14. Fails are reported per settlement date and published twice a month with a lag.
Are RCKT insiders buying or selling?
Insiders at RCKT reported 7 open-market sells worth $432K in the last 90 days and no open-market buys. Latest filing: Wilson Martin (General Counsel) on 2026-09-11.
Have RCKT insiders filed to sell?
32 Form 144 notices on file for RCKT worth $1.1M at the prices reported; 11 in the last 90 days worth $513K. Latest: Militello John filed on 2026-09-15 to sell 6,897 shares ($23K) from 2026-09-15.
Who owns 5% or more of RCKT?
No holder on file reports 5% or more of RCKT in its latest filing.
What did RCKT report last quarter?
In Q2 FY 2026 (quarter ended 2026-06-30) Rocket Pharmaceuticals reported revenue of $0, and net income of $123.2M (1.08 diluted EPS). In FY 2025 it generated -$190.0M of operating cash flow.
Which tracked 13F managers own RCKT?
7 of the 30 tracked 13F managers held RCKT shares at their latest filing, $34.8M in all. The largest: Izzy Englander's Millennium Management (4.0M shares, $13.7M), Cliff Asness's AQR Capital Management (3.4M shares, $11.6M), D. E. Shaw & Co. (951K shares, $3.3M), Renaissance Technologies (793K shares, $2.7M), Steve Cohen's Point72 Asset Management (671K shares, $2.3M), Two Sigma Investments (316K shares, $1.1M). The table above lists all 7.
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.